Skip to main content
. 2024 Oct 18;25(20):11200. doi: 10.3390/ijms252011200
ADT Androgen-deprivation therapy
CRPC Castration-resistant prostate cancer
DMSO Dimethyl sulfoxide
EGFR Epidermal growth factor receptors
EMT Epithelial–mesenchymal transition
EDTA Ethylenediaminetetraacetic acid
FBS Fetal bovine serum
FGFR Fibroblast growth factor receptor
GH Growth hormone
GHRH Growth hormone-releasing hormone
GHRH-R Growth hormone-releasing hormone receptor
GPCRs G protein-coupled receptors
ICAM-1 Intercellular adhesion molecule-1
IGF-I Insulin-like growth factor type I
MMPs Matrix metalloproteinases
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazole bromide
PBS Phosphate-buffered saline
PCa Prostate cancer
pGHRH-R Pituitary-type growth hormone-releasing hormone receptor
PI Propidium iodide
RTK Receptor tyrosine kinase
TBS Tris-buffered saline
TKIs Tyrosine kinase inhibitors
TMPS Triple-membrane-passing-signal